ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,667.56
0.08%
Dow Jones
41,985.35
0.08%
US Dollar vs MXN
20.2392
0.00%
Brent Oil
71.775
0.00%
Bitcoin
84,154.74
0.13%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Sage Therapeutics Inc (SAGE) Cotización

Sage Therapeutics Inc

Sage Therapeutics Inc (SAGE)

Sage Potash Corp
8.10
0.09
(1.12%)
Cerrado 22 Marzo 2:00PM
Delayed by 15 minutes
8.10
0.02
(0.25%)
Fuera de horario: 4:38PM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
8.10
Postura de Compra
8.04
Postura de Venta
8.50
Volume Operado de la Acción
1,038,579
7.94 Rango del Día 8.24
4.62 Rango de 52 semanas 20.32
Capitalización de Mercado [m]
497.996M
Precio Anterior
8.01
Precio de Apertura
7.94
Hora
10
@
8.5
Última hora de negociación
Volumen financiero
US$ 8,328,646
Precio Promedio Ponderado
8.0193
Volumen promedio (3 m)
1,919,566
Acciones en circulación
61,480,947
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.24
Beneficio por acción (BPA)
-6.52
turnover
41.24M
Beneficio neto
-400.67M

Acerca de Sage Therapeutics Inc

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical tri... Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical trials for post-partum depression, essential tremor, Parkinson's disease, and major depressive disorder. The company is also developing several other compounds for treatment that are in the early stage of development. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.sagerx.com
Sede
Wilmington, Delaware, USA
Fundado
-
Sage Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SAGE. The last closing price for Sage Therapeutics was US$8.01. Over the last year, Sage Therapeutics shares have traded in a share price range of US$ 4.62 to US$ 20.32.

Sage Therapeutics currently has 61,480,947 shares in issue. The market capitalisation of Sage Therapeutics is US$492.46 million. Sage Therapeutics has a price to earnings ratio (PE ratio) of -1.24.

SAGE Últimas noticias

Más noticias

Form 8-K - Current report
Edgar (US Regulatory)
04 Marzo 2025
SAGE (1.12%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
25 Febrero 2025
SAGE (1.12%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
14 Febrero 2025
SAGE (1.12%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
14 Febrero 2025
SAGE (1.12%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
14 Febrero 2025
SAGE (1.12%)

Form POS AM - Post-Effective amendments for registration statement
Edgar (US Regulatory)
11 Febrero 2025
SAGE (1.12%)

Form 8-K - Current report
Edgar (US Regulatory)
11 Febrero 2025
SAGE (1.12%)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.222.791878172597.888.227.667867997.9339757CS
40.8511.7241379317.258.226.9812862897.50117621CS
122.3941.85639229425.718.225.2419195667.15804643CS
260.577.569721115547.538.74.6213829176.71466038CS
52-11.58-58.841463414619.6820.324.6211987238.86181531CS
156-26.62-76.670506912434.7259.994.6294104221.75777906CS
260-18.67-69.74224878626.7798.3854.6284505331.93839258CS

SAGE - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Sage Therapeutics?
El precio actual de las acciones de Sage Therapeutics es US$ 8.10
¿Cuántas acciones de Sage Therapeutics están en circulación?
Sage Therapeutics tiene 61,480,947 acciones en circulación
¿Cuál es la capitalización de mercado de Sage Therapeutics?
La capitalización de mercado de Sage Therapeutics es USD 492.46M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Sage Therapeutics?
Sage Therapeutics ha negociado en un rango de US$ 4.62 a US$ 20.32 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Sage Therapeutics?
El ratio precio/beneficio de Sage Therapeutics es -1.24
¿Cuál es el ratio de efectivo a ventas de Sage Therapeutics?
El ratio de efectivo a ventas de Sage Therapeutics es 12.05
¿Cuál es la moneda de reporte de Sage Therapeutics?
Sage Therapeutics presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Sage Therapeutics?
El último ingresos anual de Sage Therapeutics es USD 41.24M
¿Cuál es el último beneficio anual de Sage Therapeutics?
El último beneficio anual de Sage Therapeutics es USD -400.67M
¿Cuál es la dirección registrada de Sage Therapeutics?
La dirección registrada de Sage Therapeutics es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Sage Therapeutics?
La dirección del sitio web de Sage Therapeutics es www.sagerx.com
¿En qué sector industrial opera Sage Therapeutics?
Sage Therapeutics opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
SGLYSingularity Future Technology Ltd
US$ 1.6799
(143.43%)
30.76M
WINVWinVest Acquisition Corporation
US$ 25.00
(107.30%)
463
VVPRVivoPower International PLC
US$ 1.2899
(52.13%)
65.08M
RNAZTransCode Therapeutics Inc
US$ 1.12
(45.45%)
216.22M
GLTOGalecto Inc
US$ 6.00
(44.93%)
10.71M
YHCLQR House Inc
US$ 0.40
(-82.38%)
38.32M
KZIAKazia Therapeutics Ltd
US$ 0.9759
(-80.02%)
55.66k
DMNDamon Inc
US$ 0.0373
(-70.02%)
304.17M
TCBPTC BioPharm Holdings PLC
US$ 0.5046
(-67.23%)
5.9M
SOWGSow Good Inc
US$ 1.53
(-44.36%)
698.02k
DMNDamon Inc
US$ 0.0373
(-70.02%)
301.97M
NVDANVIDIA Corporation
US$ 117.70
(-0.70%)
259.06M
RNAZTransCode Therapeutics Inc
US$ 1.12
(45.45%)
215.3M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9.03
(10.66%)
174.28M
HOLOMicroCloud Hologram Inc
US$ 1.00
(32.36%)
141.86M

SAGE Discussion

Ver más
Monksdream Monksdream 12 meses hace
SAGE over $10
👍️0
everton44 everton44 2 años hace
SAGE going to 36 dollars, every article and financial companies downgrading SAGE yet it goes up big. HAHAHA
👍️0
gail gail 2 años hace
i dont know anything about…

…

shorting. i am a simpleton, lol, i just trade like a normal trader.

not in this one, but made a bundle on my last few trades, including ttoo today. weeee!!
👍️0
everton44 everton44 2 años hace
we are all short selling the piss out of this now, come on board
👍️0
gail gail 2 años hace
so, they got approved yet…

..

it dropped huge today? im not in it but watching.
👍️0
AGORDON AGORDON 2 años hace
FDA approved Zuranolone for PPD. CRL for Major Depressive.
👍️0
AGORDON AGORDON 2 años hace
The FDA is still considering whether to approve zuranolone for clinical depression in addition to postpartum depression, but did not issue a decision on that indication.
👍️0
budgetthis budgetthis 3 años hace
I was gonna burn some SAGE today, in a therapeutic manner, like they do on Yellowstone to ward off evil spirits.

But no need……elevators going up today……lol.

$$ SAGE $$
👍️0
CjMitts CjMitts 3 años hace
Called the pump, How'd I know, garbby 10q report, RSI divergence. will be loading this at the bottom though with the money I make from this short, the potential of this companies pipeline is enormous.
👍️0
CjMitts CjMitts 3 años hace
Boom
👍️0
CjMitts CjMitts 3 años hace
Dont be fooled by the pump. Will be loading between 34-26. Surprised there's no talk on this page regarding the potential of this companies pipeline.
👍️0
thumper1 thumper1 5 años hace
im out high 68.eom
👍️0
thumper1 thumper1 5 años hace
bought 67.11. we will see
👍️0
NYCPuglet NYCPuglet 5 años hace
Sold at 77. Thank god. Lol.
👍️0
NYCPuglet NYCPuglet 5 años hace
In 1000 @ at 73. Easy profit flipper here. Very big whales behind this company.
👍️0
Daysinn4610 Daysinn4610 5 años hace
Ceo cfo cso all buying shares https://www.gurufocus.com/news/999044/sage-therapeutics-inc-sage-president--ceo-jeffrey-m-jonas-bought-481500-of-shares
👍️0
Daysinn4610 Daysinn4610 5 años hace
Some sage news https://www.streetinsider.com/dr/news.php?id=16261148
👍️0
keekee keekee 5 años hace
Lol....brig6and early. Crossing $80 today? The $125 may actually happen by the end if the month? We will see.
👍️0
keekee keekee 5 años hace
Seen this...though it is going to be just a few days apart. Congrats to BULLS....and I sure hope those that jumped in to short because I highlighted the stock GO BANKRUPT!!!
👍️0
keekee keekee 5 años hace
$74 now. Everyone that shorted past week is now in red. And it will get even more painful going forward. Sorry, losers!
👍️0
keekee keekee 5 años hace
$3 to $4 a day is fine for now. In a week or so we wi6see doing more than that number as we race back towards $125. When I saw BUY...and some.fools sell, all I think of is, Who the hell is their father!!!! Who do they get information from...David Einhorn or who? He just did 34% loss last year and is on track to be smothered again with the TSLA outperformance. We are headed up....Intelsat, SAGE, ASLN, FRAN, And a host of others.
👍️0
keekee keekee 5 años hace
We're headed to $80 very likely today. It's a one way train here m.j till.$100.
👍️0
Biobonic Biobonic 5 años hace
Post-hoc analysis revealed that in the MOUNTAIN Study, approximately 9% of patients in the SAGE-217 30 mg group had no measurable drug concentration, consistent with non-compliance in taking SAGE-217

In the 30mg group, 192 received the medication at the onset of the trial.

9% would approximate: 17 participants.

The trial had 28 participants withdraw by day 42. (14%) a significant number, especially since there was a good measure of efficacy.



👍️0
RJ Trotts RJ Trotts 5 años hace
I got out with 4.50 per share profit, we are both happy, enjoy your weekend. Hoping to find more winners next week.
👍️0
Nebuchadnezzar Nebuchadnezzar 5 años hace
Caught this falling knife yesterday, out up $6.45 profit
👍️0
keekee keekee 5 años hace
Watch when this stock went down from $68 yestersay. That was when I intentionally posted that I loaded. They came.and brought the it down. I reloaded. And they sre still here. Ditto for PTGX, 1, PRTY, AIHS, ASLN, AFH, SLDB, AFI, CBAY, ATIS. and a couple more. The have shorted most of these floats over 100% but still.manages tonhang on because folks have no idea that these stocks will fly double or triple. But check those out and good luck. They are mostly DOUBLERS in a month or two.
👍️0
keekee keekee 5 años hace
There are folks that short anything I buy. They are the idiots holding this down. CV lick on my name to see other stocks we play opposite. They have money but no brain. Investor money. They will shi ort anything I posted that I bought under any circumstance. They are the knes here. Ignote the selling and load. This will fly!!!
👍️0
T695 T695 5 años hace
I think we at resistance in the $66 are. The entire market will be over bought in a minute and this will sell off hard
👍️0
keekee keekee 5 años hace
Minimum close today will be $70. I will take that..from $54 and lower entry yesterday. This one is as easy...easy. will likely be trending toward $100 by month end
👍️0
T695 T695 5 años hace
Looks like my first outlook was the right one
👍️0
VictorMasonIsRight VictorMasonIsRight 5 años hace
SAGE test compromised by 9 non compliant patients?
Otherwise would have met all benchmarks?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152647122
👍️0
RJ Trotts RJ Trotts 5 años hace
up in pre-market right now, here's to hoping it bounces nicely
👍️0
T695 T695 5 años hace
On second thoughts, might me another 20% or so haircut today after all the downgrades
👍️0
T695 T695 5 años hace
It’s way over sold, but still could fall to 50ish
👍️0
T695 T695 5 años hace
I’m thinking we get a bounce from here to $66-67ish, when if it hits there it may either run back to low 70’s or pull back to 50’s then run to $70’s.... either way I see lows 50’s and lows 70’s as short term bottom and top
👍️0
RJ Trotts RJ Trotts 5 años hace
May add some here after hours, and see if it will bounce tomorrow. Best to all here. Hoping it is oversold!
👍️0
keekee keekee 5 años hace
Unfortunately, I brought them over..I mean the heavy sellers. These guys are blind in their rabid quest to trade against me. But I create losses for them. That is my mission now. We will see $100. The clueless sellers know it too!
👍️0
keekee keekee 5 años hace
Will cross $80 tom8. Must $100 by next week. The fools selling are misguided
👍️0
T695 T695 5 años hace
Might see by EOD
👍️0
keekee keekee 5 años hace
This thing may actually return to $1.25 by year end. That would be over 200% for.me. lol. In at $54 and lower..pre.
👍️0
keekee keekee 5 años hace
Loaded premkt at $53. Must get $100. Drug did not fail if you factor in the 9 candidates that did not take it. $100..let's go
👍️0
T695 T695 5 años hace
Make take a nibble at $50
👍️0
altruism altruism 5 años hace
4 according to 1 news source I saw
👍️0
Awl416 Awl416 5 años hace
How many billions that she’s off the market cap - wow
👍️0
NYCPuglet NYCPuglet 6 años hace
Such an easy predictable stock.
👍️0
cvm101 cvm101 6 años hace
So this Leerink Swann call of 1/7 is looking pretty idiotic now as stock crosses $144.00
Earlier they had downgraded and lowered target price to $80.00

Sage Therapeutics stock price target raised to $90 from $80 at Leerink
👍️0
NYCPuglet NYCPuglet 6 años hace
Once again it drops. Gotta love this flipper.
👍️0
NYCPuglet NYCPuglet 6 años hace
Wish I had funds last week to throw in. I sensed a big pop was coming.
👍️0
cvm101 cvm101 6 años hace
Well it has been - but with the approval to market the new drug its less a speculation and more an investable company. Longer term its worth $200. Most analyst target prices are in that area.
👍️0
NYCPuglet NYCPuglet 6 años hace
Yep. This is an insane flipper stock.
👍️0

Su Consulta Reciente

NASDAQ
SAGE
Sage Therapeutics
AQSE
UIFS.GB
iShares S&P 500 Financia...
AQSE
SXLK.GB
State Street Global Advi...
AQSE
WCLD.GB
WisdomTree Issuer ICAV
AQSE
SOIL.GB
WisdomTree Commodity Sec...
AQSE
SUK2.GB
Legal & General UCITS ETF
AQSE
PRES.GB
Pressure Technologies
AQSE
AVON.GB
Avon Technologies
Delayed Upgrade Clock
ADVFN Logo
México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios